Skip to main navigation Skip to search Skip to main content

Catechol-O-methyltransferase gene val158met polymorphism and depressive symptoms during early childhood

  • Haroon I. Sheikh
  • , Katie R. Kryski
  • , Heather J. Smith
  • , Lea R. Dougherty
  • , Daniel N. Klein
  • , Sara J. Bufferd
  • , Shiva M. Singh
  • , Elizabeth P. Hayden
  • Western University
  • University of Maryland, College Park
  • Stony Brook University

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Catechol-O-Methyltransferase (COMT) is a critical regulator of catecholamine levels in the brain. A functional polymorphism of the COMT gene, val158met, has been linked to internalizing symptoms (i.e., depression and anxiety) in adolescents and adults. We extended this research by investigating whether the val158met polymorphism was associated with childhood symptoms of depression and anxiety in two independent samples of young children (Ns=476 and 409). In both samples, preschool-aged children were genotyped for the COMT val158met polymorphism. Symptoms of psychopathology were assessed via parent interviews and primary caregiver reports. In both samples, children homozygous for the val allele had higher levels of depressive symptoms compared to children with at least one copy of the met allele. Our findings extend previous research in older participants by showing links between the COMT val158met polymorphism and internalizing symptoms in early childhood.

Original languageEnglish
Pages (from-to)245-252
Number of pages8
JournalAmerican Journal of Medical Genetics, Part B: Neuropsychiatric Genetics
Volume162
Issue number3
DOIs
StatePublished - Apr 2013

Keywords

  • Anxiety
  • Catechol-O-methyltransferase
  • Depression
  • Internalizing
  • Replication
  • Val158met

Fingerprint

Dive into the research topics of 'Catechol-O-methyltransferase gene val158met polymorphism and depressive symptoms during early childhood'. Together they form a unique fingerprint.

Cite this